MRO Announces Partnership with Imperial Capital Group Ltd.
Private equity firm makes investment in MRO, plans to accelerate growth of PHI disclosure management and HIE business
“We have had a strong interest in healthcare information technology and compliance-based businesses and see MRO as a great investment,” said Justin MacCormack, partner and head of healthcare investing at Imperial Capital. “MRO’s management team and healthcare solutions are among the best in the U.S. in terms of quality, technology and innovation, and we are thrilled to support the growth of this company.”
Led by a strong management team, MRO has demonstrated consistent growth over the last twelve years. Imperial Capital’s investment will provide MRO with the capital needed to accelerate this growth and reinforce its position as an industry leader.
“We are proud to have found a partner in Imperial Capital,” said Dan Heist, CEO of MRO. “They have a solid investment track record and are aligned with our vision for the future of the company. Most importantly, it remains business as usual at MRO as we continue to focus on our company’s growth and providing exceptional services and leading technology to healthcare providers.”
MRO, a leader in disclosure management and health information exchange, provides technology-driven solutions that ensure the secure, compliant and efficient exchange of protected health information (PHI). The company’s solutions include release of information (ROI), payer audit compliance and tracking, and accounting of disclosures. MRO additionally offers services and applications that support meaningful use attestation and health information exchange. MRO’s solutions can be used as a common platform across a healthcare enterprise to standardize disclosure policies and drive system-wide security and compliance. To learn more, visit www.mrocorp.com.
About Imperial Capital Group Ltd.
Imperial Capital is a Toronto-based private equity fund manager that focuses on buy-out opportunities in the Canadian and American mid-market. Currently investing from its fifth fund with commitments of $295 million, Imperial Capital invests in targeted industry niches in the healthcare, branded consumer products, and business services industries with revenue between $20 million and $200 million. For further information on Imperial Capital, please visit www.imperialcap.com.